MicroRNAs aid the assessment of programmed death ligand 1 expression in patients with non-small cell lung cancer

The qualification of patients with non-small cell lung cancer (NSCLC) for anti-programmed cell death 1 (PD-1) or anti-programmed death ligand 1 (PD-L1) antibody therapy is based on an immunohistochemistry (IHC) assessment of PD-L1 expression. Immunological checkpoint inhibitors improve the overall s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Lett
Main Authors: Grenda, Anna, Nicoś, Marcin, Szczyrek, Michał, Krawczyk, Paweł, Kucharczyk, Tomasz, Jarosz, Bożena, Pankowski, Juliusz, Sawicki, Marek, Szumiło, Justyna, Bukała, Paulina, Milanowski, Janusz
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2019
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6507482/
https://ncbi.nlm.nih.gov/pubmed/31186735
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2019.10207
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados